PNC:NYSEPNC Financial Services Group, Inc. (The) Analysis
Data as of 2026-08-01 - not real-time
$249.87
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
PNC is trading in a bullish long‑term environment, with the price comfortably above the 50‑day moving average and the 200‑day trend line, while still slightly under the short‑term 20‑day average, suggesting a potential pull‑back before resuming higher. Fundamentals are supportive: the price‑to‑earnings multiple sits well below the industry average, revenue growth is robust, and the dividend yield remains attractive with a modest payout ratio. Technical signals are mixed; the Relative Strength Index is in a neutral zone, the MACD histogram is negative and the signal line points bearish, and trading volume has been tapering, which tempers short‑term enthusiasm. Recent earnings beat expectations, revenue surged year‑over‑year, and management signaled a dividend increase, reinforcing the positive earnings narrative. Analyst consensus leans toward a buy, and the market sentiment is in the “extreme greed” zone, indicating strong investor appetite. The upside potential relative to the current price is notable, while downside risk is limited by a clear support level and a low beta, suggesting limited volatility compared with the broader market. Overall, the combination of undervalued valuation metrics, solid earnings momentum, and a sustainable dividend makes PNC a compelling candidate for investors with a medium to long horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- recent earnings beat and dividend hike
- technical resistance near current price
- decreasing volume indicating caution
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- strong revenue growth and earnings momentum
- valuation discount relative to peers
- attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- stable business model across retail and corporate banking
- consistent dividend track record
- low beta and moderate volatility supporting defensive positioning
Key Metrics & Analysis
Financial Health
Revenue Growth23.60%
Profit Margin31.37%
P/E Ratio13.7
ROE12.62%
ROA1.31%
P/B Ratio1.6
Industry P/E18.0
Technical Analysis
TrendBullish
RSI54.7
Support$245.39
Resistance$256.49
MA 20$251.25
MA 50$239.29
MA 200$216.54
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88
Valuation
Target Price$277.73
Upside/Downside11.15%
GradeUndervalued
TypeBlend
Dividend Yield3.20%
Risk Assessment
Beta0.62
Volatility17.97%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.